journal article·2022-02-22

Enhanced Chemodynamic Therapy by Cu–Fe Peroxide Nanoparticles: Tumor Microenvironment-Mediated Synergistic Fenton Reaction

Sagang Koo, Ok Kyu Park, Jonghoon Kim, Sang Ihn Han, Tae Yong Yoo, Nohyun Lee, Young Geon Kim, Hyunjoong Kim, Chaehong Lim, Jong-Seong Bae, Jin Yoo, Dokyoon Kim, Seung Hong Choi, Taeghwan Hyeon

ACS Nano· Volume 16· Issue 2
Publisher page

Abstract

An urgent need in chemodynamic therapy (CDT) is to achieve high Fenton catalytic efficiency at small doses of CDT agents. However, simple general promotion of the Fenton reaction increases the risk of damaging normal cells along with the cancer cells. Therefore, a tailored strategy to selectively enhance the Fenton reactivity in tumors, for example, by taking advantage of the characteristics of the tumor microenvironment (TME), is in high demand. Herein, a heterogeneous CDT system based on copper–iron peroxide nanoparticles (CFp NPs) is designed for TME-mediated synergistic therapy. CFp NPs degrade under the mildly acidic conditions of TME, self-supply H2O2, and the released Cu and Fe ions, with their larger portions at lower oxidation states, cooperatively facilitate hydroxyl radical production through a highly efficient catalytic loop to achieve an excellent tumor therapeutic efficacy. This is distinct from previous heterogeneous CDT systems in that the synergism is closely coupled with the Cu+-assisted conversion of Fe3+ to Fe2+ rather than their independent actions. As a result, almost complete ablation of tumors at a minimal treatment dose is demonstrated without the aid of any other therapeutic modality. Furthermore, CFp NPs generate O2 during the catalysis and exhibit a TME-responsive T1 magnetic resonance imaging contrast enhancement, which are useful for alleviating hypoxia and in vivo monitoring of tumors, respectively.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea

School of Chemical and Biological Engineering and Institute of Chemical Processes, Seoul National University, Seoul 08826, Republic of Korea

Department of Radiology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea

School of Advanced Materials Engineering, Kookmin University, Seoul 02707, Republic of Korea

Center for Biomaterials, Busan Center, Korea Basic Science Institute, Busan 46742, Republic of Korea

Biomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Republic of Korea

Department of Bionano Engineering and Bionanotechnology, Hanyang University, Ansan 15588, Republic of Korea

Funding

Hanyang University · Institute for Basic Science · Seoul National University · Creative-Pioneering Researchers Program through Seoul National University

References (62)

Show source-provided references
1. 10.1016/j.chempr.2019.05.01310.1016/j.chempr.2019.05.013 ↗
2. 10.1002/adhm.20170115610.1002/adhm.201701156 ↗
3. 10.1002/anie.20180566410.1002/anie.201805664 ↗
4. 10.1039/C7CS00471K10.1039/C7CS00471K ↗
5. 10.1002/anie.20171202710.1002/anie.201712027 ↗
6. 10.1021/acsnano.9b0583610.1021/acsnano.9b05836 ↗
7. 10.1021/acsnano.8b0189310.1021/acsnano.8b01893 ↗
8. 10.1038/s41467-017-00424-810.1038/s41467-017-00424-8 ↗
9. 10.1002/advs.20180198610.1002/advs.201801986 ↗
10. 10.1002/adfm.20190836510.1002/adfm.201908365 ↗
11. 10.1021/acsnano.8b0763510.1021/acsnano.8b07635 ↗
12. Haber F. · Proc. R. Soc. A · 1934 · 147 · 332
13. 10.1021/es011109p10.1021/es011109p ↗
14. 10.1016/j.chemosphere.2018.04.00110.1016/j.chemosphere.2018.04.001 ↗
15. 10.1002/adma.20200689210.1002/adma.202006892 ↗
16. 10.1016/j.apcatb.2013.09.01710.1016/j.apcatb.2013.09.017 ↗
17. 10.1021/jacs.9b0345710.1021/jacs.9b03457 ↗
18. 10.1021/jacs.8b0871410.1021/jacs.8b08714 ↗
19. 10.1016/j.apcatb.2012.06.01510.1016/j.apcatb.2012.06.015 ↗
20. 10.1016/j.apcatb.2014.09.04710.1016/j.apcatb.2014.09.047 ↗
21. 10.1016/j.chemosphere.2019.12500210.1016/j.chemosphere.2019.125002 ↗
22. 10.1016/j.apcatb.2017.02.03210.1016/j.apcatb.2017.02.032 ↗
23. 10.1021/acscentsci.0c0039710.1021/acscentsci.0c00397 ↗
24. 10.1002/adma.20200506210.1002/adma.202005062 ↗
25. 10.1002/anie.20201441510.1002/anie.202014415 ↗
26. 10.1002/anie.20200629010.1002/anie.202006290 ↗
27. 10.1038/nrc395810.1038/nrc3958 ↗
28. 10.1038/nrc311010.1038/nrc3110 ↗
29. 10.1038/nrc70410.1038/nrc704 ↗
30. 10.1021/jacs.8b0107210.1021/jacs.8b01072 ↗
31. 10.1038/ncomms351610.1038/ncomms3516 ↗
32. 10.1021/ic401587r10.1021/ic401587r ↗
33. 10.1021/acsnano.6b0554110.1021/acsnano.6b05541 ↗
34. 10.1038/nrc306410.1038/nrc3064 ↗
35. 10.1038/nrc234410.1038/nrc2344 ↗
36. 10.1021/jacs.7b0555910.1021/jacs.7b05559 ↗
37. 10.1021/ar900002610.1021/ar9000026 ↗
38. 10.1021/cm903155710.1021/cm9031557 ↗
39. 10.1021/nl202721q10.1021/nl202721q ↗
40. 10.1002/adhm.20140002310.1002/adhm.201400023 ↗
41. 10.1021/ja803920b10.1021/ja803920b ↗
42. 10.1021/jacs.0c0156210.1021/jacs.0c01562 ↗
43. 10.1021/jacs.1c0351010.1021/jacs.1c03510 ↗
44. 10.1021/jacs.7b1099710.1021/jacs.7b10997 ↗
45. 10.1002/anie.20190993910.1002/anie.201909939 ↗
46. 10.1038/srep2904910.1038/srep29049 ↗
47. 10.1039/C5TA01108F10.1039/C5TA01108F ↗
48. 10.1021/ja00214a07010.1021/ja00214a070 ↗
49. 10.1021/ja01184a09810.1021/ja01184a098 ↗
50. 10.1038/nrc147810.1038/nrc1478 ↗
51. 10.1016/j.apcatb.2009.04.02410.1016/j.apcatb.2009.04.024 ↗
52. 10.1016/j.tips.2006.09.00210.1016/j.tips.2006.09.002 ↗
53. 10.1021/ja203340u10.1021/ja203340u ↗
54. 10.1002/smll.20100052310.1002/smll.201000523 ↗
55. 10.1002/adma.20100026010.1002/adma.201000260 ↗
56. 10.1002/adfm.20200691810.1002/adfm.202006918 ↗
57. 10.1038/ncb342910.1038/ncb3429 ↗
58. 10.1038/nm.299410.1038/nm.2994 ↗
59. 10.1002/anie.20090512610.1002/anie.200905126 ↗
60. 10.1039/b815548h10.1039/b815548h ↗
61. 10.1039/C7CS00877E10.1039/C7CS00877E ↗
62. 10.7150/thno.346510.7150/thno.3465 ↗